Patent · US Active

Nanoscale carriers for the delivery or co-delivery of chemotherapeutics, nucleic acids and photosensitizers

US10517822B2 · kind B2 · utility

6Cited by
23References
13Claims
0Family size

Assignees

Inventors

Key dates

Filing dateNov 6, 2014
Grant dateDec 31, 2019
Priority date
Expiry dateNov 6, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2320/32
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Nanoscale coordination polymer nanoparticles for the co-delivery of multiple therapeutic agents are described. The multiple therapeutic agents can include a combination of different chemotherapeutic agents, a combination of one or more chemotherapeutic agents and one or more nucleic acids, such as small interfering RNA (siRNA) or microRNA, a combination of one or more chemotherapeutic agents and a photosensitizer (i.e., for use in photodynamic therapy), or a plurality of different siRNAs. Pharmaceutical formulations including the nanoparticles, methods of using the nanoparticles to treat cancer, and methods of making the nanoparticles are also described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.